Sickle cell adhesion to laminin: Potential role for the α5 chain

Blood

Volumn 92, Issue 8, 1998, Pages 2951-2958

  Lee, Sheritha P ^b   Cunningham, Michelle L ^b   Hines, Patrick C ^b   Joneckis, Christopher C ^b   Orringer, Eugene P ^b   Parise, Leslie V ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ADHESION; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

EID: 0032532056     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2951.420k30_2951_2958     Document Type: Article

References (60)

1. Embury SH, Hebbel RP, Steinberg MH, Mohandas N: Pattoogenesis of vaso-occlusion, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 311
2. Beutler E: Erythrocyte disorders: Anemias related to abnormal globin, in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology (ed 4). New York, NY, McGraw-Hill, 1990, p 613
3. Thomas AN, Pattison C, Serjeant GR: Causes of death in sickle cell disease in Jamaica. Br Med J 285:633, 1982
4. Merkel KH, Ginsberg PL, Parker JC, Donovan MJ: Cerebrovascular disease in sickle cell anemia: A clinical pathological and radiological correlate. Stroke 9:45, 1978
5. Russel MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63:162, 1984
6. Ham TH, Castle WB: Relation of increased hypotonic fragility and of erythrostasis to the mechanism of hemolysis in certain anemias. Trans Assoc Am Phys 55:127, 1940
7. Eaton WA, Hofrichter J: Sickle cell hemoglobin polymerization. Adv Protein Chem 40:63, 1990
8. Mozzarelli A, Hofrichter J, Eaton WA: Delay time of hemoglobin S polymerization prevents most cells from sickling in vitro. Science 237:500, 1987
9. Hoover R, Rubin R, Wise G, Warren R: Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 54:872, 1979
10. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism of microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
11. Kaul DK, Fabry ME, Windisch P, Baez S, Nagel RL: Erythrocytes in sickle cell anemia are heterogeneous in their Theological and hemodynamic characteristics. J Clin Invest 72:22, 1983
12. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 86:3356, 1989
13. Francis RB, Haywood LJ: Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 84:611, 1992
14. Malave I, Perdomo Y, Escalona E, Rodriguez E, Anchustegui M, Malave H, Arends T: Levels of tumor necrosis factor α/cachectin (TNFα) in sera from patients with sickle cell disease. Acta Haematol 90:172, 1993
15. Leichtman DA, Brewer GJ: Elevated plasma levels of fibrinopeptide A during sickle cell anemia pain crisis-evidence for intravascular coagulation. Am J Hematol 5:183, 1978
16. Green D, Scott JP: Is sickle cell crisis a thrombotic event? Am J Hematol 23:317, 1986
17. Francis RB: Elevated fibrin D-dimer fragment in sickle cell anemia: Evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis 19:105, 1989
18. Ofosu FA, Kuranstin-Mills J, Safa T, Siegel R, Lessin LS: Coagulation and fibrinolysis are enhanced in sickle cell disease. FASEB J 5:A523, 1991
19. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263, 1989
20. Blei F, Fancher T, Guarini L: Elevated levels of circulating molecules of potential endothelial origin in sickle cell disease. Blood 84:409a, 1994 (abstr, suppl 1)
21. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584, 1997
22. Klug PP, Kay N, Jensen WN: Endothelial cell and vascular damage in the sickle cell disorder. Blood Cells 8:175, 1982
23. Joneckis CC, Shock DD, Cunningham ML, Orringer EP, Parise LV: Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. Blood 87:4862, 1996
24. Hillery CA, Du MC, Montgomery RR, Scott JP: Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 87:4879, 1996
25. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR: The laminin α chains: Expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol 137:685, 1997
26. Engel J: Laminins and other strange proteins. Biochemistry 31:10643, 1992
27. Timpl R: Structure and biological activity of basement membrane proteins. Eur J Biochem 18:487, 1989
28. Sorette MP, Shiffer K, Clark MR: Improved isolation of normal human reticulocytes via exploitation of chloride-dependent potassium transport. Blood 80:249, 1992
29. Hebbel RP, Mohandas N: Sickle cell adherence, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 217
30. Bookchin RM, Lew VL: Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am 10:1242, 1996
31. Parise LV, Phillips DR: Fibronectin-binding properties of the purified platelet glycoprotein Ib-IIIa complex. J Biol Chem 261:14011, 1986
32. Barbarino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
33. Hemler ME, Elices MJ, Parker C, Takada Y: Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 114:45, 1990
34. Yamada Y, Kleinman HK: Functional domains of cell adhesion molecules. Curr Opin Cell Biol 4:819, 1992
35. Aumailley M, Nurcombe V, Edgar D, Paulsson M, Timpl R: The cellular interactions of laminin fragments cell adhesion correlates with two fragment-specific high affinity binding sites. J Biol Chem 262: 11532, 1987
36. Goodman SL, Deutzmann R, Von Der Mark K: Two distinct cell-binding domains in laminin can independently promote neuronal cell adhesion and spreading. J Cell Biol 105:589, 1987
37. Timpl R, Johansson S, Van Delden V, Oberbaumer I, Hook M: Characterization of protease resistant fragments of laminin mediating attachment and spreading of rat hepatocytes. J Biol Chem 258:8922, 1983
38. Grant DS, Tashiro K-I, Segui-Real B, Yamada Y, Martin GR, Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58:933, 1989
39. Tashiro K-I, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, Yamada Y: A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 264:16174, 1989
40. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR: Distribution and isolation of four laminin variants: Tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1:731, 1990
41. Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S, Manthorpe M: Mapping of domains in human laminin using monoclonal antibodies: Localization of the neurite-promoting site. J Cell Biol 103:2457, 1986
42. Beck K, Hunter I, Engel J: Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J 4:148, 1990
43. Tiger C-F, Champliaud M-F, Pedrosa-Domellof F, Thornell L-E, Ekblom P, Gullberg D: Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J Biol Chem 272:28590, 1997
44. Kikkawa Y, Sanzen N, Sekiguchi K: Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. J Biol Chem 273:15854, 1998
45. Church HJ, Aplin JD: BeWo choriocarcinoma cells produce laminin 10. Biochem J 332:491, 1998
46. Mohandas N, Evans E: Adherence of sickle erythrocytes to vascular endothelial cells: Requirement for both cell membrane changes and plasma factors. Blood 64:282, 1984
47. Hebbel RP, Boogaerts MAC, Eaton JW, Steinberg MH: Erythrocyte adherence to endothelium in sickle cell anemia: A possible determinant of disease severity. N Engl J Med 302:992, 1980
48. Udani M, Zen Q, Cottman M, Leonard N, Jefferson S, Daymont C, Truskey G, Telen MJ: Basal cell adhesion molecule/Lutheran protein: The receptor critical for sickle cell adhesion to laminin. J Clin Invest 101:2550, 1998
49. Jaspars LH, van der Linden HC, Scheffer GL, Scheper RJ, Meijer CJ: Monoclonal antibody 4C7 recognizes an endothelial basement membrane component that is selectively expressed in capillaries of lymphoid follicles. J Pathol 170:121, 1993
50. Schittny JC, Timpl R, Engel J: High resolution immunoelectron microscopic localization of functional domains of laminin, nidogen, and heparan sulfate proteoglycan in epithelial basement membrane of mouse cornea reveals different topological orientations. J Cell Biol 107:1599, 1988
51. Durkin ME, Loechel F, Mattei M-G, Gilpin BJ, Albrechtsen R, Wewer UM: Tissue-specific expression of the human laminin α5 chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near locus for the ragged (Ra) mutation. FEBS Lett 411:296, 1997
52. Engvall E, Wewer UM: Domains of laminin. J Cell Biochem 61:493, 1996
53. Ryan M, Tizard R, VanDevanter DR, Carter WG: Cloning of the LAMA3 gene encoding the α3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 269:22779, 1994
54. Richards AJ, Al-Imara L, Carter NP, Lloyd JC, Leversha MA, Pope FM: Localization of the gene (LAMA4) to chromosome 6Q21 and isolation of a partial cDNA encoding a variant laminin A chain. Genomics 22:237, 1994
55. Miner JH, Lewis RM, Sanes JR: Molecular cloning of a novel laminin chain, α5, and widespread expression in adult mouse tissues. J Biol Chem 270:28523, 1995
56. Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP, Fardeau M: Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 317:351, 1994
57. Baudoin C, Aberdam D, Christiano AM, Uitto J, Ortonne JP, Meneguzzi G: Impaired expression of the LAMA3 gene causes Herlitz junctional epidermolysis bullosa. J Invest Dermatol 104:597, 1995
58. Sorokin LM, Pausch F, Frieser M, Kroger S, Ohage E, Deutzmann R: Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation. Dev Biol 189:285, 1997
59. Grabowski EF: Sickle erythrocytes adhere to endothelial cell monolayers (ECM's) exposed to flowing blood. Prog Clin Biol Res 240:167, 1987
60. Shapiro BS, Ballas SK: The acute painful episode, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 531